Key Insights

Highlights

Treatment Research

3 treatments under study, led by Emboshield

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown2

Clinical Trials (2)

Showing 2 of 2 trials
NCT06058676Unknown

Prediction of Hyperperfusion After Carotid Stenting by Multi-parameter Characteristics Based on Cerebral Autoregulation

NCT04904250Not ApplicableUnknown

Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting

Showing all 2 trials

Research Network

Common Treatments

  • Emboshield1
  • Carotid Artery Stenting1
  • Spider1

Active Sponsors

  • Xuanwu Hospital, Beijing2

Top Investigators

  • Liqun Jiao, MD, PhD1

    Department of Interventional Neuroradiology, Department of Neurosurgery, International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University

  • yingqi Xing, MD1

    Department of Vascular Ultrasonography, Xuanwu Hospital. Beijing Institute of Brain Disorders.

Related Conditions

  • Dynamic Cerebral Autoregulation1
  • Cerebral Artery Stenosis1
  • Stroke1
  • Carotid Stenosis1

Activity Timeline